IDEA4RC FHIR Implementation Guide
0.1.0 - CI Build 150

IDEA4RC FHIR Implementation Guide, published by IDEA4RC Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/idea4rc/ and changes regularly. See the Directory of published versions

Table of Contents

.. 0 Table of Contents
... 1 IDEA4RC FHIR IG - Home Page
... 2 IDEA4RC Model Overview
... 3 IDEA4RC Detailed ERD Model
... 4 IDEA4RC Logical Models
... 5 Useful Downloads
... 6 Condition-secondaryCancer-eu-i4rc Relationships
... 7 Encounter-eu-i4rc Relationships
... 8 Condition-primaryCancer-eu-i4rc Relationships
... 9 sarcoma-cancer-stage-group Relationships
... 10 hn-cancer-stage-group Relationships
... 11 episodeOfCare-eu-i4rc Relationships
... 12 MedicationAdministration-eu-i4rc Relationships
... 13 Subject Relationships
... 14 PatientFollowUp Relationships
... 15 EpisodeEvent Relationships
... 16 OtherTreatment Relationships
... 17 HospitalPatientRecords Relationships
... 18 HnStage Relationships
... 19 CancerEpisode Relationships
... 20 AdverseEvent Relationships
... 21 GeneticTestExpression Relationships
... 22 SarcomaStage Relationships
... 23 Surgery Relationships
... 24 Radiotherapy Relationships
... 25 Artifacts Summary
.... 25.1 Adverse Event
.... 25.2 Cancer Episode
.... 25.3 Episode Event
.... 25.4 Genetic Test Expression
.... 25.5 Head and Neck Stage
.... 25.6 Hospital Patient Records
.... 25.7 Other Local Treatment
.... 25.8 Pathological Report Info
.... 25.9 Patient
.... 25.10 Patient Follow-Up
.... 25.11 Radiotherapy
.... 25.12 Sarcoma Stage
.... 25.13 Surgery
.... 25.14 Systemic Treatment
.... 25.15 Treatment Response
.... 25.16 Cancer Episode Model to this guide Map
.... 25.17 Episode Event Model to this guide Map
.... 25.18 Genetic Test Expression Model to this guide Map
.... 25.19 Genetic Test to this guide Map
.... 25.20 Head and Neck Stage Model to this guide Map
.... 25.21 Hospital Patient Records Model to this guide Map
.... 25.22 Patient (Subject) Model to this guide Map
.... 25.23 Patient Follow up Model to this guide Map
.... 25.24 Radiotherapy Model to this guide Map
.... 25.25 Sarcoma Stage Model to this guide Map
.... 25.26 Surgery Model to this guide Map
.... 25.27 Observation: Alcohol use
.... 25.28 Observation: Cancer Treatment
.... 25.29 Observation: Charlson Comorbidity Index
.... 25.30 Observation: Comorbidities
.... 25.31 Observation: ECOG Performance Status
.... 25.32 Observation: Karnofsky Performance Status
.... 25.33 Observation: Occurrence of the other cancer
.... 25.34 Observation: Tobacco use
.... 25.35 Patient: IDEA4RC
.... 25.36 Condition: Metastatic Cancer
.... 25.37 Condition: Primary Cancer
.... 25.38 Observation: Diagnosis details
.... 25.39 Observation: Head Neck Cancer Stage Group
.... 25.40 Observation: Localized Category (Stage, Sarcoma)
.... 25.41 Observation: LocoRegional Category (Stage, Sarcoma)
.... 25.42 Observation: Radiological Extra-nodal extension (rENE)
.... 25.43 Observation: Sarcoma Cancer Stage Group
.... 25.44 Observation: TNM Distant Metastases Category
.... 25.45 Observation: TNM Primary Tumor Category
.... 25.46 Observation: TNM Regional Nodes Category
.... 25.47 Encounter: IDEA4RC
.... 25.48 Observation: date of the last contact
.... 25.49 Observation: Status at the Last Follow Up
.... 25.50 Procedure: Surgery
.... 25.51 Procedure: Radiotherapy
.... 25.52 MedicationAdministration: Chemotherapy
.... 25.53 EpisodeOfCare: IDEA4RC
.... 25.54 AdverseEvent: IDEA4RC
.... 25.55 Bundle: IDEA4RC
.... 25.56 Observation: test results
.... 25.57 Observation: Yes / No assertions
.... 25.58 Procedure: Other Treatment
.... 25.59 Body Location Qualifier
.... 25.60 Condition related to resource
.... 25.61 Laterality Qualifier
.... 25.62 Performed Timing
.... 25.63 Previous Status
.... 25.64 Race Extension
.... 25.65 Radiotherapy Dose Delivered To Volume Extension
.... 25.66 Radiotherapy Energy or Isotope
.... 25.67 Radiotherapy Modality And Technique Extension
.... 25.68 Radiotherapy Modality Extension
.... 25.69 Radiotherapy Number of Sessions Extension
.... 25.70 Radiotherapy Technique Extension
.... 25.71 Relapse Type
.... 25.72 Same custodian flag
.... 25.73 Affected Organs (surgery)
.... 25.74 Alcohol Usage Status: Athena
.... 25.75 Alcohol Usage Status: SNOMED CT
.... 25.76 Antineoplastic and immunostimulating agents
.... 25.77 Beam Quality
.... 25.78 Body site qualifier
.... 25.79 Calculated|Estimated
.... 25.80 Cancer Chondro Osseous Tumours: Athena
.... 25.81 Cancer diagnosis: Athena
.... 25.82 Cancer Endometrial stromal and related Tumors: Athena
.... 25.83 Cancer Event Type: Athena
.... 25.84 Cancer Histology Adenocarcinoma: Athena
.... 25.85 Cancer Histology Neuroendocrine: Athena
.... 25.86 Cancer Histology Odontogenic Carcinoma: Athena
.... 25.87 Cancer Histology SNUC: Athena
.... 25.88 Cancer Histology Squamous: Athena
.... 25.89 Cancer Histology Subgroup Adipocytic Tumours: Athena
.... 25.90 Cancer Histology Subgroup Fmt Tumours: Athena
.... 25.91 Cancer Histology Subgroup So called Fibrohistiocytic Tumours: Athena
.... 25.92 Cancer Miscellanious mesenchimal tumors: Athena
.... 25.93 Cancer Mixed epithelial and mesenchymal tumours: Athena
.... 25.94 Cancer Pericytic Perivascular Tumours: Athena
.... 25.95 Cancer Peripheral Nerve Sheath Tumors: Athena
.... 25.96 Cancer Skeletal Muscle Tumours: Athena
.... 25.97 Cancer Smooth Muscle Tumours: Athena
.... 25.98 Cancer Stage Grading: Athena
.... 25.99 Cancer Stage Group Value: Athena
.... 25.100 Cancer Stage Group: Athena
.... 25.101 Cancer Tumors Of Uncertain Differentiation: Athena
.... 25.102 Cancer undif. small round cell sarcomas of bone and soft tissue: Athena
.... 25.103 Cancer Vascular Tumours: Athena
.... 25.104 Chemotherapy cumulative dose units
.... 25.105 Comorbidities: Athena
.... 25.106 Comorbidities: SNOMED
.... 25.107 Country: athena
.... 25.108 Current Smoking Status: Athena
.... 25.109 ECOG Performance Status
.... 25.110 Event Type
.... 25.111 Extranodal Extension
.... 25.112 Gender: Athena
.... 25.113 Genetic Tests performed (Yes/no/Unk)
.... 25.114 Genito urinary subsite: Athena
.... 25.115 Hypopharynx subsite: Athena
.... 25.116 Hypopharynx subsite: Snomed CT
.... 25.117 Intra abdominal subsite: Athena
.... 25.118 Intra thoracic subsite : Athena
.... 25.119 Larynx subsite: Athena
.... 25.120 Larynx subsite: Snomed CT
.... 25.121 Lip subsite: Athena
.... 25.122 Lip subsite: Snomed CT
.... 25.123 Margins After Surgery
.... 25.124 Metastatis: Athena
.... 25.125 Nasal cavity and paranasal sinuses subsite: Athena
.... 25.126 Nasal cavity and paranasal sinuses subsite: Snomed CT
.... 25.127 Nasopharynx subsite: Athena
.... 25.128 Nasopharynx subsite: Snomed CT
.... 25.129 Not Performed|Unknown
.... 25.130 Observation Codes for Distant Metastases Category
.... 25.131 Observation Codes for Primary Tumor Category
.... 25.132 Observation Codes for Regional Node Category
.... 25.133 Occurrence of other cancer
.... 25.134 Oral cavity subsite: Athena
.... 25.135 Oral cavity subsite: Snomed CT
.... 25.136 Oropharynx subsite: Athena
.... 25.137 Oropharynx subsite: Snomed CT
.... 25.138 Pathological M
.... 25.139 Pathological N
.... 25.140 Pathological T
.... 25.141 Positive-Negative-No Test: Athena
.... 25.142 Race
.... 25.143 Radiotherapy Device Type
.... 25.144 Reason For End Of Treatment
.... 25.145 Sarcoma Staging: localized disease
.... 25.146 Sarcoma Staging: loco-regional category
.... 25.147 Setting Radiotherapy
.... 25.148 Simple measures
.... 25.149 Site of metastasis
.... 25.150 Site rare (IDEA4RC)
.... 25.151 Smoking Status: LOINC
.... 25.152 Status at the Last Follow Up
.... 25.153 Subsites: Athena
.... 25.154 Subsites: SNOMED CT
.... 25.155 Surgery Complication
.... 25.156 Surgery Intention
.... 25.157 Surgery Outcome
.... 25.158 Surgical Complications
.... 25.159 Surgical Procedure Category
.... 25.160 Surgical Procedure Type
.... 25.161 TNM Distant Metastases Category Value Set
.... 25.162 TNM Primary Tumor Category Value Set
.... 25.163 TNM Regional Nodes Category Value Set
.... 25.164 Tobacco Product
.... 25.165 Treatment completed as planned
.... 25.166 Treatment Response
.... 25.167 Treatment Setting
.... 25.168 Treatment Technique
.... 25.169 Trunk wall subsite: Athena
.... 25.170 Type of Biopsy
.... 25.171 Type of Diagnosis
.... 25.172 Type of surgical approach
.... 25.173 Type of Systemic Treatment
.... 25.174 Type of Treatment
.... 25.175 Types of Yes/No observations
.... 25.176 Upper and Lower limbs subsite: Athena
.... 25.177 Yes-No-Unk: Athena
.... 25.178 IDEA4RC Code System
.... 25.179 Other Treatment to this guide Map
.... 25.180 Radiotherapy Model to this guide Map
.... 25.181 Actor: Head and Neck
.... 25.182 Actor: Sarcoma
.... 25.183 Condition: Grade 2 tumor with several body sites and evidences
.... 25.184 Condition: Metastasis bone and pleura
.... 25.185 Condition: NOT CLEAR WHAT IT REPRESENTS..TO BE DISCUSSED
.... 25.186 Condition: Stable Disease
.... 25.187 encounter-id-14
.... 25.188 EpisodeOfCare
.... 25.189 GOFSH-GENERATED-id-28
.... 25.190 GOFSH-GENERATED-id-30
.... 25.191 GOFSH-GENERATED-id-36
.... 25.192 Observation: Alcohol use
.... 25.193 Observation: BMI
.... 25.194 Observation: C reactive protein Positive
.... 25.195 Observation: Charlson Comorbidity Index
.... 25.196 Observation: comorbidity
.... 25.197 Observation: date of the last contact
.... 25.198 Observation: Diagnosis
.... 25.199 Observation: Dimension of Tumor
.... 25.200 Observation: Distant metastases clinical M1
.... 25.201 Observation: Distant metastases pathology M1
.... 25.202 Observation: ECOG Performance Status score
.... 25.203 Observation: Epstein Barr virus DNA Negative
.... 25.204 Observation: gene Mutation Analysis Performed yes
.... 25.205 Observation: Human papilloma virus Negative
.... 25.206 Observation: immunohiostochemestry analysis performed
.... 25.207 Observation: Karnofsky Performance Status score
.... 25.208 Observation: Number of mitoses per HPF
.... 25.209 Observation: Occurrence of other Cancer: Hamartoma
.... 25.210 Observation: Primary tumor clinical T0
.... 25.211 Observation: Primary tumor pathological T0
.... 25.212 Observation: Radiological Extra-nodal extension
.... 25.213 Observation: Regional lymph nodes Clinical N1
.... 25.214 Observation: Regional lymph nodes pathology N3b
.... 25.215 Observation: Surgery treatment occurred
.... 25.216 Observation: TNM clinical stage grouping
.... 25.217 Observation: TNM pathology stage grouping
.... 25.218 Observation: Tobacco use panel
.... 25.219 Patient: race extension
.... 25.220 Procedure: Isolated limb perfusion